124.79
-1.48
(-1.17%)
At close: January 10 at 4:00:00 PM EST
124.58
-0.21
(-0.17%)
After hours: January 10 at 7:59:14 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 53,376 | 6 |
Sales | 18,121 | 3 |
Net Shares Purchased (Sold) | 35,255 | 9 |
Total Insider Shares Held | 4.19M | -- |
% Net Shares Purchased (Sold) | 0.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
ESTEPAN IAN MICHAEL Chief Financial Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 27, 2024 |
WIGZELL HANS LENNART RUDOLF Director | Conversion of Exercise of derivative security at price 13.71 per share. | Direct | 143,955 | Dec 12, 2024 |
WIGZELL HANS LENNART RUDOLF Director | Sale at price 124.84 per share. | Direct | 1,310,820 | Dec 12, 2024 |
BOOR KATHRYN JEAN Director | Sale at price 125.55 per share. | Direct | 205,400 | Dec 5, 2024 |
ROTHFUSS CRISTIN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 26, 2024 |
CONNELLY DEIRDRE P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 12, 2024 |
BEHRENS M KATHLEEN Director | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 4, 2024 |
ESTEPAN IAN MICHAEL Chief Financial Officer | Sale at price 137.36 per share. | Direct | 822,100 | Aug 30, 2024 |
CHAMBERS MICHAEL ANDREW Director | Purchase at price 133.07 - 134.66 per share. | Indirect | 4,955,728 | Aug 16, 2024 |
BEHRENS M KATHLEEN Director | Conversion of Exercise of derivative security at price 13.90 per share. | Direct | 208,500 | Jul 3, 2024 |
BROWN RYAN EDWARD General Counsel | Conversion of Exercise of derivative security at price 62.77 per share. | Direct | 1,475,095 | Jun 25, 2024 |
BROWN RYAN EDWARD General Counsel | Sale at price 158.07 - 164.52 per share. | Direct | 6,296,029 | Jun 25, 2024 |
ARIF BILAL Chief Technology Officer | Sale at price 162.31 - 167.13 per share. | Direct | 1,917,891 | Jun 25, 2024 |
RODINO-KLAPAC LOUISE Officer | -- | Direct | -- | Jun 21, 2024 |
ESTEPAN IAN MICHAEL Chief Financial Officer | -- | Direct | -- | Jun 21, 2024 |
ARIF BILAL Chief Technology Officer | -- | Direct | -- | Jun 21, 2024 |
MURRAY DALLAN Officer | -- | Direct | -- | Jun 21, 2024 |
MURRAY DALLAN Officer | Sale at price 140.00 per share. | Direct | 508,900 | May 2, 2024 |
BOOR KATHRYN JEAN Director | Sale at price 122.93 per share. | Direct | 93,550 | Mar 11, 2024 |
WIGZELL HANS LENNART RUDOLF Director | Conversion of Exercise of derivative security at price 13.90 per share. | Direct | 208,500 | Mar 8, 2024 |
WIGZELL HANS LENNART RUDOLF Director | Sale at price 122.39 - 123.85 per share. | Direct | 1,848,795 | Mar 8, 2024 |
MAYO STEPHEN L. Director | Sale at price 122.96 per share. | Direct | 385,480 | Mar 5, 2024 |
WIGZELL HANS LENNART RUDOLF Director | Conversion of Exercise of derivative security at price 128.67 per share. | Direct | 473,377 | Mar 1, 2024 |
ESTEPAN IAN MICHAEL Chief Financial Officer | Sale at price 128.30 per share. | Direct | 153,960 | Mar 1, 2024 |
BROWN RYAN EDWARD General Counsel | Sale at price 125.34 per share. | Direct | 250,680 | Mar 1, 2024 |
ARIF BILAL Chief Technology Officer | Sale at price 128.58 - 129.71 per share. | Direct | 257,676 | Mar 1, 2024 |
BOOR KATHRYN JEAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
RODINO-KLAPAC LOUISE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
ESTEPAN IAN MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
BROWN RYAN EDWARD General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
MAYO STEPHEN L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
CHAMBERS MICHAEL ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
ARIF BILAL Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
BEHRENS M KATHLEEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
BARRY RICHARD J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
WIGZELL HANS LENNART RUDOLF Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
NICAISE CLAUDE M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
INGRAM DOUGLAS S Chief Executive Officer | Purchase at price 78.57 - 81.26 per share. | Direct | 2,001,800 | Nov 3, 2023 |
BARRY RICHARD J Director | Purchase at price 78.81 per share. | Indirect | 3,940,500 | Nov 3, 2023 |
BEHRENS M KATHLEEN Director | Conversion of Exercise of derivative security at price 29.03 per share. | Direct | 435,450 | Nov 3, 2023 |
CHAMBERS MICHAEL ANDREW Director | Purchase at price 109.19 - 109.89 per share. | Indirect | 1,092,429 | Aug 14, 2023 |
CHAMBERS MICHAEL ANDREW Director | Purchase at price 108.05 per share. | Indirect | 2,559,272 | Aug 11, 2023 |
CHAMBERS MICHAEL ANDREW Director | Purchase at price 104.67 - 106.26 per share. | Indirect | 3,701,067 | Aug 10, 2023 |
WIGZELL HANS LENNART RUDOLF Director | Conversion of Exercise of derivative security at price 29.03 per share. | Direct | 435,450 | Aug 4, 2023 |
WIGZELL HANS LENNART RUDOLF Director | Sale at price 106.72 per share. | Direct | 1,600,800 | Aug 4, 2023 |
BOOR KATHRYN JEAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
RODINO-KLAPAC LOUISE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
ESTEPAN IAN MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
BROWN RYAN EDWARD General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
MAYO STEPHEN L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
Related Tickers
ARWR Arrowhead Pharmaceuticals, Inc.
18.49
-6.38%
ALNY Alnylam Pharmaceuticals, Inc.
237.98
-1.07%
BMRN BioMarin Pharmaceutical Inc.
67.38
-1.46%
INCY Incyte Corporation
70.54
-3.54%
LEGN Legend Biotech Corporation
33.62
+2.59%
MDGL Madrigal Pharmaceuticals, Inc.
338.91
+1.66%
BPMC Blueprint Medicines Corporation
87.43
-3.53%
DYN Dyne Therapeutics, Inc.
15.87
-31.15%
BLUE bluebird bio, Inc.
8.46
0.00%
AXSM Axsome Therapeutics, Inc.
80.05
-3.05%